Loading insider details...
Beta
Latest Form 4 (Aug 26, 2026): Grant/Award of 5,800,051 GOSS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 26, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 5,800,051 | n/a |
| Mar 20, 2026 | Gossamer Bio, Inc. (GOSS) | Disposition to Issuer | 506,250 | n/a |
| Jan 5, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 84,500 | n/a |
| Oct 2, 2025 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 125,000 | n/a |
| Mar 6, 2025 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 440,000 | n/a |
| Mar 19, 2024 | Gossamer Bio, Inc. (GOSS) | Sale | 4,018 | $5.3K |
| Jan 4, 2024 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 375,000 | n/a |
| Nov 23, 2023 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 125,000 | n/a |
| May 9, 2023 | Gossamer Bio, Inc. (GOSS) | Disposition to Issuer | 48,500 | n/a |
| Mar 22, 2023 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 157,500 | n/a |